Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

100,000 doses of Russia's Sputnik V vaccine arrive in Venezuela

Published 02/13/2021, 02:41 PM
Updated 02/13/2021, 02:56 PM
© Reuters. FILE PHOTO: A shipment of doses of the Sputnik V vaccine arrives in Buenos Aires

CARACAS (Reuters) - The first 100,000 doses of Russia's Sputnik V coronavirus vaccine arrived in Venezuela on Saturday.

In a tweet, President Nicolas Maduro said medical and health personnel would be the first to receive the vaccine, "given their exposure to COVID-19."

The vaccines arrived at Caracas' international airport on a special flight from Moscow on Conviasa airlines, Venezuela's state carrier, according to Reuters witnesses and images shown by state television VTV.

"Here is the vaccine to serve the most vulnerable sectors with the highest priority, health personnel, for example; it is a vaccine that addresses the most grave cases of patients with morbidities," said Vice President Delcy Rodriguez.

"It is a vaccine that seeks to reduce community transmission," she added.

Maduro has previously said after healthcare workers, "vulnerable sectors" would be next in line, followed by teachers.

For months Venezuela's government has said the South American country would receive 10 million doses of the Sputnik V vaccine, although the vaccine's maker has not confirmed that figure.

In addition to Sputnik V, the Pan American Health Organization's chief of mission said last week that between 1.4 million and 2.4 million doses of the AstraZeneca (NASDAQ:AZN) Plc vaccine had been reserved for Venezuela. At $10 per dose, those vaccines would cost between $140 million and $240 million.

Venezuelan government officials and opposition leaders have met to discuss buying coronavirus vaccines through the international COVAX program using cash frozen in the United States by economic sanctions, but no deal has been made.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In a Thursday evening state television appearance, Maduro said the government was working on a $300 million deal with the Pan American Health Organization for vaccine supplies, but did not provide details.

Authorities on Friday reported 132,259 coronavirus cases in the country and 1,267 deaths, but medical unions and opponents have said the figure is likely higher.

The government has authorized a relaxation of the national quarantine for two weeks for the next Carnival (NYSE:CUK) holiday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.